Repligen (RGEN) shares outstanding

Shares outstanding · fiscal 2025
56.56M

Repligen (RGEN) had 56.56M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 1.1% higher than the 55.94M of fiscal 2024. Figures as of 18 Nov 2026, 11:57 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
56.56M
Change on fiscal 2024
+1.1%
Growth, 5 years
+0.9% a year
Growth, 10 years
+5.4% a year
Highest on record
57.46Mfiscal 2022
Lowest on record
30.75Mfiscal 2010
Fiscal years on record
162010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Repligen shares outstanding, in more detail

The market data feed counts 63.92M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 0.9% a year; over ten years the rate was 5.4% a year. Across the 16 fiscal years on record (2010–2025), the highest was 57.46M in fiscal 2022 and the lowest 30.75M in fiscal 2010.

History · 16 fiscal years

Shares outstanding by fiscal year

Repligen shares outstanding, year by year

Repligen (RGEN) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202556.56M 1.1% up
202455.94M 0.8% down
202356.38M 1.9% down
202257.46M 0.3% up
202157.27M 6.1% up
202053.99M 9.7% up
201949.21M 8.2% up
201845.47M 16.1% up
201739.15M 14.0% up
201634.36M 2.3% up
201533.58M 0.9% up
201433.26M 2.6% up
201332.41M 3.7% up
201231.25M 1.5% up
201130.78M 0.1% up
201030.75M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Repligen and comparable companies
CompanyShares outstandingFiscal year
Kymera Therapeutics KYMR84.49M2025
DaVita DVA75.89M2025
Halozyme Therapeutics HALO123.90M2025
Universal Health Services UHS64.46M2025
Repligen RGEN56.56M2025
Bio-Techne TECH157.01M2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RGEN

Repligen, figure by figure

Repligen (RGEN) overview: price, valuation and scorecardAll health care companies by market value

Repligen shares outstanding: questions and answers

How many shares does Repligen have?

Repligen (RGEN) had 56.56M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 1.1% higher than the 55.94M of fiscal 2024. The market data feed counts 63.92M shares outstanding today.

What is the growth rate of Repligen's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 0.9% a year; over ten years the rate was 5.4% a year.

What are the highest and lowest diluted share count figures on record for Repligen?

Across the 16 fiscal years on record (2010–2025), the highest was 57.46M in fiscal 2022 and the lowest 30.75M in fiscal 2010.

How is Repligen's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Repligen it is on record here for 16 fiscal years, 2010 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Repligen (RGEN) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/RGEN/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.